Head and Neck Diseases by Alexandros G.Sfakianakis: Molecular Testing for Stage IV Non-Small Cell Lung Cancer Patients with Targetable Mutations Following Disease Progression.

Παρασκευή 13 Απριλίου 2018

Molecular Testing for Stage IV Non-Small Cell Lung Cancer Patients with Targetable Mutations Following Disease Progression.

Molecular Testing for Stage IV Non-Small Cell Lung Cancer Patients with Targetable Mutations Following Disease Progression.

Arch Pathol Lab Med. 2018 Apr 12;:

Authors: Saxena A

PMID: 29648887 [PubMed - as supplied by publisher]

https://ift.tt/2v9nQCr

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Εγγραφή σε: Σχόλια ανάρτησης (Atom)